FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
SOL #: FDABAA-25-00123_AwardAward Notice
Overview
Buyer
Health And Human Services
Food And Drug Administration
FDA Office of Acquisitions and Grants Services
Rockville, MD, 20857, United States
Place of Performance
Silver Spring, MD
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
PSC
General Science And Technology R&D Services; General Science And Technology; Basic Research (AJ11)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Nov 24, 2025
2
Last Updated
Jan 13, 2026
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Please see attached Spreadsheet for all contracts awarded in this oppertunity. A total of 13 Contracts were awarded in FY23 from this BAA Announcement.
People
Points of Contact
Ian WeissPRIMARY